Publicaciones (37) Publicaciones de Pedro Enrique Mondejar Lopez

2024

  1. Maternal and fetal outcomes in multiparous women with Cystic Fibrosis

    Respiratory Medicine, Vol. 228

2023

  1. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

2022

  1. Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  2. Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation A Phase 3b, Randomized, Placebo-controlled Study

    American Journal of Respiratory and Critical Care Medicine, Vol. 206, Núm. 11, pp. 1361-1369

  3. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

    Journal of Cystic Fibrosis, Vol. 21, Núm. 4, pp. e221-e231

  4. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation

    Respiratory Medicine, Vol. 192

  5. Incidence and Prevalence of Children's Diffuse Lung Disease in Spain

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 22-29

2021

  1. A multimodal approach to detect and monitor early lung disease in cystic fibrosis

    Expert Review of Respiratory Medicine, Vol. 15, Núm. 6, pp. 761-772

  2. COVID-19 vaccine prioritisation for people with cystic fibrosis

    Journal of Cystic Fibrosis

  3. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

    Journal of Cystic Fibrosis, Vol. 20, Núm. 1, pp. 25-30

  4. Factors associated to functional recovery of left vocal fold motion impairment at two-years-old age in very preterm infants

    International Journal of Pediatric Otorhinolaryngology, Vol. 142

  5. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

    Journal of Cystic Fibrosis, Vol. 20, Núm. 4, pp. 566-577

2020

  1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

  2. Impact of early caffeine therapy in preterm newborns on infant lung function

    Pediatric Pulmonology, Vol. 55, Núm. 1, pp. 102-107

  3. Preschool asthma symptoms in children born preterm: The relevance of lung function in infancy

    Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-8

  4. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

    Journal of Cystic Fibrosis, Vol. 19, Núm. 6, pp. 868-871

2019

  1. Follow-up protocol of patients with cystic fibrosis diagnosed by newborn screening

    Anales de Pediatria, Vol. 90, Núm. 4, pp. 251.e1-251.e10

  2. Malformaciones pulmonares congénitas

    Manual de pediatría (Ergon), pp. 983-989

  3. Protocolo de seguimiento de pacientes con fibrosis quística diagnosticados por cribado neonatal

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 90, Núm. 4, pp. 251-251

  4. Spanish multicentre study on morbidity and pathogenicity of tracheal bronchus in children

    Pediatric Pulmonology, Vol. 54, Núm. 10, pp. 1610-1616